UK markets open in 7 hours 22 minutes

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.050.00 (0.00%)
At close: 04:00PM EDT
12.05 0.00 (0.00%)
After hours: 06:41PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
509,338
509,338
537,840
535,031
494,366
Cost of revenue
128,280
128,280
114,867
114,877
106,501
Gross profit
381,058
381,058
422,973
420,154
387,865
Operating expenses
Research development
223,062
223,062
206,085
201,303
132,010
Selling general and administrative
390,866
390,866
306,411
263,184
225,454
Total operating expenses
613,928
613,928
512,496
464,487
357,464
Operating income or loss
-232,870
-232,870
-89,523
-44,333
30,401
Interest expense
3,319
3,319
3,334
3,440
17,582
Total other income/expenses net
-797
-797
-3,523
-4,032
2,648
Income before tax
-191,740
-191,740
-81,846
-52,075
18,102
Income tax expense
15,303
15,303
10,688
6,276
-1,706
Income from continuing operations
-207,043
-207,043
-92,534
-58,351
19,808
Net income
-207,043
-207,043
-92,534
-58,351
19,808
Net income available to common shareholders
-207,043
-207,043
-92,534
-58,351
19,808
Basic EPS
-1.86
-1.95
-0.88
-0.56
0.20
Diluted EPS
-1.86
-1.95
-0.88
-0.56
0.18
Basic average shares
105,910
106,391
104,660
103,433
100,931
Diluted average shares
105,910
106,391
104,660
103,433
108,878